GenMont Biotech Inc

TW:3164 Taiwan Biotechnology

Market Cap

$47.57 Million

NT$1.57 Billion TWD

Market Cap Rank

#23481 Global

#1398 in Taiwan

Share Price

NT$18.30

Change (1 day)

+0.83%

52-Week Range

NT$17.20 - NT$22.40

All Time High

NT$30.54

GenMont Biotech Inc - Asset Resilience Ratio

Latest as of September 2025: 19.50%

GenMont Biotech Inc (3164) has an Asset Resilience Ratio of 19.50% as of September 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing.

Liquid Assets

NT$307.92 Million

Cash + Short-term Investments

Total Assets

NT$1.58 Billion

All company assets

Resilience Assessment

Good

Financial Resilience Level

Asset Resilience Ratio Trend (2003–2024)

This chart shows how GenMont Biotech Inc's Asset Resilience Ratio has changed over time. Compare with other companies' asset resilience ratios.

Liquid Assets Composition Over Time

This chart breaks down GenMont Biotech Inc's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	NT$0.00	0%
Short-term Investments	NT$307.92 Million	19.5%
Total Liquid Assets	NT$307.92 Million	19.50%

Asset Resilience Insights

Good Liquidity Position: GenMont Biotech Inc maintains a healthy 19.50% of assets in liquid form.
This level provides good financial flexibility while maintaining productive asset deployment.
The company has significant short-term investments, indicating active treasury management.